Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Side effects of sirolimus.

S Merkel1, N Mogilevskaja, M Mengel

  • 1Department of Nephrology, Medical School of Hannover, Hannover, Germany. Merkel.Saskia@mh-hannover.de

Transplantation Proceedings
|May 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-scale neural slowing measured with electroencephalography indexes secondary thalamic degeneration in stroke.

medRxiv : the preprint server for health sciences·2026
Same author

Zero liquid discharge recovery system for maximized tailings water reuse.

Journal of environmental management·2025
Same author

Reperfusion failure after successful thrombectomy of large vessel occlusion stroke: clinical and imaging evidence.

Frontiers in neurology·2025
Same author

Upper limb movement quality measures: comparing IMUs and optical motion capture in stroke patients performing a drinking task.

Frontiers in digital health·2024
Same author

Characterization of atherosclerotic plaques in blood vessels with low oxygenated blood and blood pressure (Pulmonary trunk): role of growth differentiation factor-15 (GDF-15).

BMC cardiovascular disorders·2021
Same author

Differentiating migraine, cervicogenic headache and asymptomatic individuals based on physical examination findings: a systematic review and meta-analysis.

BMC musculoskeletal disorders·2021

Sirolimus offers improved renal transplant function but can cause adverse events like increased proteinuria and glomerulopathy. Caution is advised, especially for patients with existing glomerular conditions.

Area of Science:

  • Nephrology
  • Immunosuppression
  • Transplantation

Background:

  • The mTOR inhibitor sirolimus demonstrates improved renal transplant function over calcineurin inhibitors.
  • Sirolimus is often used as a conversion therapy for malignancies, deteriorating renal function, or hypertension post-transplant.

Purpose of the Study:

  • To retrospectively evaluate adverse events associated with sirolimus in renal transplant recipients.
  • To identify specific adverse events and their incidence in patients receiving sirolimus.

Main Methods:

  • Retrospective analysis of 119 renal transplant patients treated with sirolimus.
  • Evaluation of patient data including reasons for conversion, de novo initiation, and adverse event monitoring.

Main Results:

Related Experiment Videos

  • Common adverse events included elevated serum lipids and decreased hemoglobin.
  • Occasional adverse events comprised arthralgia, edema, gastrointestinal issues, skin disorders, electrolyte imbalances, and infections.
  • A significant 31% of patients experienced doubling or more of proteinuria, with 9/13 biopsies showing glomerulopathy (6 de novo, 3 recurrent).

Conclusions:

  • Sirolimus is associated with manageable adverse events but requires careful monitoring.
  • Increased proteinuria and glomerulopathy are notable risks, particularly in patients with pre-existing glomerular disease.